|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48.34 USD | +2.86% |
|
-4.46% | -8.07% |
| 30/06 | CRISPR Therapeutics AG(NasdaqGM:CRSP) added to Russell Small Cap Comp Growth Benchmark | CI |
| 30/06 | CRISPR Therapeutics AG(NasdaqGM:CRSP) added to Russell 2500 Growth Benchmark | CI |
Chart calendar CRISPR Therapeutics AG
Upcoming events on CRISPR Therapeutics AG
No events available
Past events on CRISPR Therapeutics AG
| 04/06/2026 | Annual General Meeting | 11:30 am |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 371 297 24.87% | 37,3 13,9 167.84% | 3,51 6,12 -42.66% | 40,1 | 163 | 647 |
|
EBITDA Million USD | Released Forecast Spread | -203 -292 30.64% | -447 -470 4.77% | -645 -590 -9.41% | -474 | -439 | -609 |
|
EBIT Million USD | Released Forecast Spread | -223 -313 28.93% | -467 -520 10.26% | -665 -628 -5.84% | -538 | -455 | -312 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -151 -255 40.89% | -363 -429 15.38% | -578 -545 -5.96% | -501 | -416 | -130 |
|
Net income Million USD | Released Forecast Spread | -154 -261 41.15% | -366 -427 14.29% | -582 -548 -6.12% | -488 | -376 | -160 |
|
EPS USD | Released Forecast Spread | -1,94 -3,35 42.17% | -4,34 -5,08 14.5% | -6,47 -6,16 -4.96% | -4,89 | -3,65 | -1,60 |
| Announcement Date | 21/02/24 | 11/02/25 | 12/02/26 | - |
Quarterly results
| Fiscal Period | March | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,60 7,13 -91.56% | 35,7 7,29 389.72% | 0,87 5,96 -85.5% | 0,89 6,44 -86.15% | 0,89 8,95 -90.07% | 0,86 4,02 -78.51% | 1,46 4,25 -65.73% | 7,43 | 16,6 | 19,3 | 25,2 | 26,8 | 30,5 | 33,0 |
|
EBITDA Million USD | Released Forecast Spread | -105 -149 29.44% | -59,7 -104 42.39% | -128 -112 -14.04% | -149 -120 -24.72% | -126 -116 -8.39% | -123 | -124 | -127 | -105 | |||||
|
EBIT Million USD | Released Forecast Spread | -110 -139 20.99% | -64,6 -118 45.36% | -148 -127 -17.22% | -133 -140 4.87% | -132 -128 -3.09% | -155 -129 -19.58% | -130 -138 5.32% | -134 | -141 | -147 | -111 | -108 | -102 | -101 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -85,1 -120 28.88% | -36,6 -100 63.41% | -135 -104 -29.73% | -207 -123 -67.94% | -106 -110 4.23% | -130 -109 -18.78% | -122 -124 1.19% | -117 | -129 | -136 | -97,3 | -91,7 | -88,4 | -85,3 |
|
Net income Million USD | Released Forecast Spread | -85,9 -118 26.93% | -37,3 -99,7 62.57% | -136 -104 -30.78% | -209 -124 -68.09% | -106 -110 3.57% | -131 -109 -20.28% | -123 -117 -4.9% | -115 | -123 | -128 | -98,0 | -92,5 | -89,2 | -86,2 |
|
EPS USD | Released Forecast Spread | -1,01 -1,38 27.02% | -0,44 -1,12 60.82% | -1,58 -1,21 -30.18% | -2,40 -1,39 -72.81% | -1,17 -1,24 5.7% | -1,37 -1,15 -18.7% | -1,28 -1,26 -1.82% | -1,18 | -1,18 | -1,24 | -0,88 | -0,84 | -0,82 | -0,81 |
| Announcement Date | 05/11/24 | 11/02/25 | 06/05/25 | 04/08/25 | 10/11/25 | 12/02/26 | 04/05/26 | - | - | - | - | - | - | - |
| 22/07/2026 | Earnings release - Q2 2026 | 10:00 am | |
| 22/07/2026 | Earnings presentation | 05:30 pm | |
| 23/07/2026 | Earnings presentation | 06:30 pm | |
| 23/07/2026 | Earnings release - Q2 2026 | ||
| 23/07/2026 | Earnings presentation | 05:30 pm | |
| 23/07/2026 | Earnings release - Q2 2026 | ||
| 23/07/2026 | Earnings release - Q2 2026 | 11:30 am | |
| 24/07/2026 | Earnings release - Q1 2027 | ||
| 24/07/2026 | Board of Directors Meeting | ||
| 25/07/2026 | Earnings presentation | 10:00 am |
Past sector events for CRISPR Therapeutics AG
| 20/07/2026 | Board of Directors Meeting | 04:30 pm | |
| 20/07/2026 | Extraordinary General Meeting | 12:00 pm | |
| 17/07/2026 | Présentation aux Actionnaires / Analystes | ||
| 16/07/2026 | Significant Split/Dividend | 09:30 am | |
| 16/07/2026 | Ex-dividend date - 0.2 CNY | 09:30 am | |
| 16/07/2026 | Extraordinary General Meeting | 07:30 am | |
| 15/07/2026 | Extraordinary General Meeting | 10:30 am | |
| 15/07/2026 | Présentation aux Actionnaires / Analystes | 10:30 am | |
| 14/07/2026 | Information meeting | 06:00 pm | |
| 14/07/2026 | Earnings presentation | 05:30 pm |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- CRSP Stock
- Calendar CRISPR Therapeutics AG
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















